United Therapeutics SG&A Expenses 2010-2024 | UTHR

United Therapeutics sg&a expenses for the twelve months ending September 30, 2024 were $0.673B, a 32.53% increase year-over-year.

  • United Therapeutics annual sg&a expenses for 2023 were $0.477B, a 1.04% decline from 2022.
  • United Therapeutics annual sg&a expenses for 2022 were $0.482B, a 3.23% increase from 2021.
  • United Therapeutics annual sg&a expenses for 2021 were $0.467B, a 10.17% increase from 2020.

United Therapeutics SG&A Expenses 2010-2024 | UTHR

  • United Therapeutics annual sg&a expenses for 2023 were $0.477B, a 1.04% decline from 2022.
  • United Therapeutics annual sg&a expenses for 2022 were $0.482B, a 3.23% increase from 2021.
  • United Therapeutics annual sg&a expenses for 2021 were $0.467B, a 10.17% increase from 2020.